AI is transforming healthcare across the Middle East and North Africa, with Saudi Arabia, the UAE and Egypt leading the charge. Nicos Savva, Professor of Management Science at London Business School, examines how the technology is augmenting clinicians, improving access and raising critical ethical questions.
Artificial Intelligence (AI) is transforming healthcare across the globe, but in the Middle East and North Africa (MENA), this transformation feels particularly urgent and ambitious. Governments across the region have placed healthcare innovation at the heart of their national agendas – from Saudi Vision 2030 to the UAE’s AI Strategy 2031, making the sector a proving ground for AI’s ability to improve lives at scale.
The progress is already visible. Saudi Arabia has attracted global headlines by launching the world’s first AI-powered doctor’s clinic, where Shanghai-based Synyi AI’s ‘Dr Hua’ is diagnosing and prescribing treatment for respiratory ailments. In the UAE, leading hospitals such as Cleveland Clinic Abu Dhabi and Sheikh Shakhbout Medical City are deploying AI to assist radiologists in detecting cancers, fractures and heart disease earlier and more accurately. Egypt, meanwhile, has begun piloting AI-powered diagnostic tools to expand access in rural areas, tackling a chronic shortage of physicians.
These developments might evoke images of fully autonomous ‘AI doctors,’ but I believe the more meaningful and immediate story is one of augmentation, not replacement.
Augmenting clinicians, not replacing them
Healthcare in the MENA region is defined by both excellence and challenge. World-class hospitals in Gulf capitals coexist with rural areas underserved by medical staff. In this complex ecosystem, AI is beginning its journey in support roles – handling medical documentation, flagging prescription errors and reducing administrative burdens.
For clinicians, this means less time spent on paperwork and more time with patients. Across the GCC, where physician burnout is an increasing concern, this is a game changer. For patients, it means consultations that feel more human – where a doctor in Riyadh or Dubai makes eye contact, listens and engages fully, while AI quietly manages the records in the background.
Healthcare systems benefit as well. In countries where reimbursement and funding are tied to documentation quality, AI’s ability to produce precise, comprehensive medical notes strengthens both patient safety and financial sustainability.
AI’s quiet revolution and the equity question
Of course, AI’s trajectory will not stop at augmentation. Over time, its role will expand into active advisory capacities recommending diagnoses, suggesting treatment options and perhaps even managing routine follow-ups. In resource-limited environments, this may be the difference between having access to care or having none at all.
Some observers worry this could create a two-tier system: affluent patients receiving care from human doctors, while others make do with an ‘inferior’ AI substitute. In the MENA context, however, the opposite may be true. In rural Egypt, Jordan, or Morocco, where access to specialists is scarce, AI could serve as the great leveller bringing expertise to those who otherwise lack it.
Looking further ahead, as AI systems improve, we may even face a reversal of expectations: affluent patients insisting on being treated by ‘Dr AI,’ while those unable to afford such systems rely on the less accurate, less efficient human alternative. This inversion challenges our assumptions and underscores the ethical responsibilities that policymakers across the region must now grapple with.
Looking ahead
The MENA region is not standing on the sidelines of this revolution; it is helping to shape it. Saudi Arabia’s pioneering AI clinics, the UAE’s predictive analytics in hospitals and Egypt’s efforts to scale AI-powered diagnostics for underserved communities are all part of a bigger story: one where technology strengthens human expertise, improves access and raises the quality of care.
The future of healthcare in MENA is not about choosing between human and machine. It is about building partnerships between clinicians and AI and ensuring that the benefits are distributed fairly across society. If governments, healthcare providers and innovators get this balance right, the region could become not only an adopter of AI in healthcare, but a global leader in defining how technology and humanity work together for healthier lives.
